Cargando…
Body Mass Index Is Inversely Associated with Risk of Postmenopausal Interval Breast Cancer: Results from the Women’s Health Initiative
SIMPLE SUMMARY: Breast cancer diagnosed between a negative screening mammogram and the next regularly scheduled mammographic exam is called interval breast cancer. It is often diagnosed at more advanced stages than screening-detected cancers. While body mass index (BMI) is a risk factor for postmeno...
Autores principales: | Zhang, Zhenzhen, Curran, Grace, Shannon, Jackilen, Velie, Ellen M., Irvin, Veronica L., Manson, JoAnn E., Simon, Michael S., Altinok Dindar, Duygu, Pyle, Chelsea, Schedin, Pepper, Tabung, Fred K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264843/ https://www.ncbi.nlm.nih.gov/pubmed/35804998 http://dx.doi.org/10.3390/cancers14133228 |
Ejemplares similares
-
Comparison of Mortality Among Participants of Women’s Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers
por: Irvin, Veronica L., et al.
Publicado: (2020) -
Insights Into the Oral Microbiome and Barrett's Esophagus Early Detection: A Narrative Review
por: Zhang, Zhenzhen, et al.
Publicado: (2021) -
Association between Gut Microbiota and Breast Cancer: Diet as a Potential Modulating Factor
por: Altinok Dindar, Duygu, et al.
Publicado: (2023) -
Proinflammatory and Hyperinsulinemic Dietary Patterns Are Associated With Specific Profiles of Biomarkers Predictive of Chronic Inflammation, Glucose-Insulin Dysregulation, and Dyslipidemia in Postmenopausal Women
por: Shi, Ni, et al.
Publicado: (2021) -
Metformin inhibits stromal aromatase expression and tumor progression in a rodent model of postmenopausal breast cancer
por: Giles, Erin D., et al.
Publicado: (2018)